Safety and Activity of the Chemotherapy-free Triplet of Ublituximab, TGR-1202 and ibrutinib in Relapsed B-cell Malignancies.

Drug Category : Array
Conference Category : Array
Lead Author : Fowler N, O'Brien S, et al.
Published Date : 02/06/2015
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/ASCO%20Triplet%20Fowler%20Final%20Presentation.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top